SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-108717
Filing Date
2024-04-24
Accepted
2024-04-24 09:26:57
Documents
19
Period of Report
2024-04-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d740386d8k.htm   iXBRL 8-K 37687
2 EX-1.1 d740386dex11.htm EX-1.1 180181
3 EX-5.1 d740386dex51.htm EX-5.1 55201
4 EX-99.1 d740386dex991.htm EX-99.1 6888
5 EX-99.2 d740386dex992.htm EX-99.2 7735
10 GRAPHIC g740386g0424090849168.jpg GRAPHIC 2678
  Complete submission text file 0001193125-24-108717.txt   530533

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cnta-20240423.xsd EX-101.SCH 3868
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnta-20240423_def.xml EX-101.DEF 14486
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnta-20240423_lab.xml EX-101.LAB 24178
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnta-20240423_pre.xml EX-101.PRE 15584
23 EXTRACTED XBRL INSTANCE DOCUMENT d740386d8k_htm.xml XML 6428
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 24867032
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)